{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:27:09Z","timestamp":1785252429210,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bbmt.2019.04.028","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T20:40:34Z","timestamp":1556829634000},"page":"1832-1836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant"],"prefix":"10.1016","volume":"25","author":[{"given":"Anant","family":"Gokarn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Toshniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amogh","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankalp","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Bonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Punatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9520-795X","authenticated-orcid":false,"given":"Lingaraj","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Kelkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Khattry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.04.028_bib0001","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1016\/j.bbmt.2015.11.795","article-title":"Cytomegalovirus viremia and relapse after haploidentical hematopoietic cell transplantation","volume":"22","author":"Goldsmith","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbmt.2017.09.018","article-title":"Prevention of cytomegalovirus reactivation in haploidentical stem cell transplantation","volume":"24","author":"Hammerstrom","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0003","series-title":"Thomas\u2019 Hematopoietic Cell Transplantation","first-page":"1069","article-title":"Cytomegalovirus infection","author":"Zaia","year":"2016"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/338624","article-title":"High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection","volume":"185","author":"Nichols","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0005","first-page":"348","article-title":"Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India","volume":"20","author":"Kothari","year":"2002","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0006","doi-asserted-by":"crossref","first-page":"e26639","DOI":"10.1002\/pbc.26639","article-title":"Cytomegalovirus reactivation posthematopoietic stem cell transplantation (HSCT) and type of graft: A step toward rationalizing CMV testing and positively impacting the economics of HSCT in developing countries","volume":"64","author":"Uppuluri","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0007","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0008","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1016\/j.transproceed.2005.10.116","article-title":"A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients","volume":"37","author":"John","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0009","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.bmt.1704694","article-title":"Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection","volume":"34","author":"Avery","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1399-3062.2006.00170.x","article-title":"Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation","volume":"9","author":"Battiwalla","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0011","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1016\/j.bbmt.2013.12.376","article-title":"Lower incidence of CMV reactivation following allogeneic stem cell transplantation despite a high seroprevalence: a single centre experience","volume":"20","author":"George","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0012","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3855\/jidc.2947","article-title":"Cytomegalovirus reactivation following hematopoietic stem cell transplantation","volume":"7","author":"Sharma","year":"2013","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0013","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbmt.2015.11.010","article-title":"Haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in children with advanced acute leukemia with fludarabine-, busulfan-, and melphalan-based conditioning","volume":"22","author":"Jaiswal","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0014","first-page":"107","article-title":"Cytomegalovirus infection after haploidentical stem cell transplantation may reduce relapse risk in leukemia","volume":"55","author":"Lin","year":"2016","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000053979","article-title":"Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide","volume":"42","author":"Waldman","year":"1999","journal-title":"Intervirology"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0016","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1016\/j.bbmt.2013.12.405","article-title":"Use of leflunomide in the treatment of recalcitrant CMV infection in immunocompromised patients","volume":"20","author":"Mori","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.028_bib0017","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1182\/blood.V106.11.5379.5379","article-title":"Rapid clearance of CMV-antigenemia with combination treatment of foscarnet and leflunomide in a 2-year old boy with refractory CMV disease after allogeneic HSCT for JMML","volume":"106","author":"Ehlert","year":"2005","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119302848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119302848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:07:28Z","timestamp":1761059248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119302848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1083879119302848"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.04.028","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}